announcement, page-43

like any speccie, it has gained a reputation of a p&d stock. and most people who have popped up this evening on this forum seem sure about a drop tomorrow - ofcourse they hold NO stock! :) ... surprise!

the company is about to launch its product australia-wide, with plans to then go international. it has finally come as close as possible to production - and once tests are done it will be full steam ahead. so why is this still a speccie????

it will be an OTC drug - with a growing customer base. the company has patents in the US and India and a distributor in the US.

i agree that in the beginning stages a biotech is a game of roulette, but this one has grown past that stage.

hang in there holders, unlike other biotechs that give a hint of promise, this one has a real product thats being tested before production and sales kick in.